1. Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S, et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open 2018;2018:hoy004.
3. Shah K, Bhat P, Bhat R, Sultana R. An update on recurrent early pregnancy loss: causes, controversies and cure. J Clin Diagn Res 2018;12:1-5.
4. Wang NF, Kolte AM, Larsen EC, Nielsen HS, Christiansen OB. Immunologic abnormalities, treatments, and recurrent pregnancy loss: what is real and what is not? Clin Obstet Gynecol 2016;59:509-23.
5. Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol 2009;2:76-83.
7. De Santis M, Cavaliere AF, Straface G, Di Gianantonio E, Caruso A. Inherited and acquired thrombophilia: pregnancy outcome and treatment. Reprod Toxicol 2006;22:227-33.
8. Divya Pandey D, Gupta S. Current update on recurrent pregnancy loss. J Basic Clin Reprod Sci 2019;8:1-6.
9. Coriu L, Ungureanu R, Talmaci R, Uscatescu V, Cirstoiu M, Coriu D, et al. Hereditary thrombophilia and thrombotic events in pregnancy: single-center experience. J Med Life 2014;7:567-71.
12. Murin S, Marelich GP, Arroliga AC, Matthay RA. Hereditary thrombophilia and venous thromboembolism. Am J Respir Crit Care Med 1998;158:1369-73.
14. El Hachem H, Crepaux V, May-Panloup P, Descamps P, Legendre G, Bouet PE. Recurrent pregnancy loss: current perspectives. Int J Womens Health 2017;9:331-45.
16. Torabi R, Zarei S, Zeraati H, Zarnani AH, Akhondi MM, Hadavi R, et al. Combination of thrombophilic gene polymorphisms as a cause of increased the risk of recurrent pregnancy loss. J Reprod Infertil 2012;13:89-94.
17. Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 2006;55:360-8.
18. Mishra P, Singh K, Tyagi S, Juneja R, Mahapatra M. Inherited and acquired thrombophilia in women of Indian ethnicity with recurrent pregnancy loss: an observational study from North India. Indian J Pathol Microbiol 2021;64:741-5.
19. Sedano-Balbás S, Lyons M, Cleary B, Murray M, Gaffney G, Maher M. Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women. J Pregnancy 2011;2011:232840.
20. McNamee K, Dawood F, Farquharson R. Recurrent miscarriage and thrombophilia: an update. Curr Opin Obstet Gynecol 2012;24:229-34.
25. Jyotsna PL, Sharma S, Trivedi SS. Coagulation inhibitors and activated protein C resistance in recurrent pregnancy losses in Indian women. Indian J Pathol Microbiol 2011;54:752-5.
26. Aiach M, Borgel D, Gaussem P, Emmerich J, Alhenc-Gelas M, Gandrille S. Protein C and protein S deficiencies. Semin Hematol 1997;34:205-16.
27. Soare AM, Popa C. Deficiencies of proteins C, S and antithrombin and activated protein C resistance--their involvement in the occurrence of arterial thromboses. J Med Life 2010;3:412-5.
29. Sabadell J, Casellas M, Alijotas-Reig J, Arellano-Rodrigo E, Cabero L. Inherited antithrombin deficiency and pregnancy: maternal and fetal outcomes. Eur J Obstet Gynecol Reprod Biol 2010;149:47-51.
30. Tait RC, Walker ID, Perry DJ, Islam SI, Daly ME, McCall F, et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994;87:106-12.
40. Raziel A, Kornberg Y, Friedler S, Schachter M, Sela BA, Ron-El R. Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss. Am J Reprod Immunol 2001;45:65-71.
41. Ivanov P, Tsvyatkovska T, Konova E, Komsa-Penkova R. Inherited thrombophilia and IVF failure: the impact of coagulation disorders on implantation process. Am J Reprod Immunol 2012;68:189-98.
42. Grandone E, Piazza G. Thrombophilia, inflammation, and recurrent pregnancy loss: a case-based review. Semin Reprod Med 2021;39:62-8.
43. Parveen F, Shukla A, Agarwal S. Cytokine gene polymorphisms in northern Indian women with recurrent miscarriages. Fertil Steril 2013;99:433-40.
44. Wawrusiewicz-Kurylonek N, Krętowski AJ, Posmyk R. Frequency of thrombophilia associated genes variants: population-based study. BMC Med Genet 2020;9(21):198.
45. Pereza N, Ostojić S, Kapović M, Peterlin B. Systematic review and meta-analysis of genetic association studies in idiopathic recurrent spontaneous abortion. Fertil Steril 2017;107:150-9e2.
46. Parveen F, Agrawal S. A study of forty-seven single nucleotide polymorphisms among recurrent miscarriage using classification and regression tree analysis. Am J Reprod Immunol 2013;70:529-37.
49. Kim MS, Gu BH, Song S, Choi BC, Cha DH, Baek KH. ITI-H4, as a biomarker in the serum of recurrent pregnancy loss (RPL) patients. Mol Biosyst 2011;7:1430-40.
50. Laisk T, Soares ALG, Ferreira T, Painter JN, Censin JC, Laber S, et al. The genetic architecture of sporadic and multiple consecutive miscarriage. Nat Commun 2020;11:5980.
53. de Ligt J, Veltman JA, Vissers LE. Point mutations as a source of de novo genetic disease. Curr Opin Genet Dev 2013;23:257-63.
54. Lindström S, Wang L, Smith EN, Gordon W, van Hylckama Vlieg A, de Andrade M, et al. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Blood 2019;134:1645-57.
55. Klarin D, Busenkell E, Judy R, Lynch J, Levin M, Haessler J, et al. Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease. Nat Genet 2019;51:1574-9.
57. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 2002;99:333-41.